Vnitr Lek 1996, 42(7):451-453

[Recombinant interferon alfa in the treatment of essential thrombocythemia].

E Tóthová, M Fricová, B Mudronová, N Stecová, E Svorcová, A Kafková, T Guman
Oddelenie klinickej hematológie FNsP, Kosice.

Essential thrombocythaemia, a clonal myeloproliferative disease characterized by a persisting increase of the number of thrombocytes, their abnormal morphology and function, is a special clinical and therapeutic problem which calls for a comprehensive approach. Based on a group of their own patients and on data from the literature, the authors discuss the asset of interferon alpha in the treatment of essential thrombocythaemia.

Keywords: Adult; Female; Humans; Interferon Type I, therapeutic use, ; Male; Middle Aged; Recombinant Proteins; Thrombocytosis, therapy,

Published: July 1, 1996  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tóthová E, Fricová M, Mudronová B, Stecová N, Svorcová E, Kafková A, Guman T. [Recombinant interferon alfa in the treatment of essential thrombocythemia]. Vnitr Lek. 1996;42(7):451-453.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.